Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, the enzyme responsible for inactivating the incretin hormone glucagon-like peptide-1 (GLP-1), exerts protective effects against DCM in streptozotocin-induced diabetic rats [310]. Here, DPP4 is linked to familial dilated cardiomyopathy.